Marc Lebel
Impact in
- Microbiology top 0.2%
- Bacterial Infections and Vaccines
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 42
- Antibiotics Pharmacokinetics and Efficacy 38
-
- Antibiotic Resistance in Bacteria 12
- Co-authors
- George H. McCrackenFrançois ValléeMichel G. BergeronKurt OlsenGeorge A. SyrogiannopoulosSunita M. StewartBetsy D. KennardBishara J. Freij
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)The Pediatric Infectious Disease Journal (10 papers)Clinical Pharmacology & Therapeutics (6 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)PEDIATRICS (4 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Marc Lebel
117 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Microbiology 874
- Molecular Medicine 353
- Pharmacology 886
- Epidemiology 1.6k
- Applied Microbiology and Biotechnology 66
Countries citing papers authored by Marc Lebel
This map shows the geographic impact of Marc Lebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lebel more than expected).
Fields of papers citing papers by Marc Lebel
This network shows the impact of papers produced by Marc Lebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lebel. The network helps show where Marc Lebel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc Lebel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2015 | 0 | |
| 5 | 2015 | 0 | |
| 6 | 2012 | 13 | |
| 7 | 2010 | 18 | |
| 8 | 2008 | 36 | |
| 9 | 2001 | 48 | |
| 10 | 2001 | 36 | |
| 11 | 2000 | 37 | |
| 12 | The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996. | 2000 | 3 |
| 13 | 1999 | 71 | |
| 14 | 1998 | 48 | |
| 15 | 1994 | 11 | |
| 16 | 1993 | 3 | |
| 17 | 1993 | 14 | |
| 18 | 1990 | 3 | |
| 19 | 1988 | 208 | |
| 20 | 1987 | 30 |
About Marc Lebel
Marc Lebel is a scholar working on Pharmacology, Molecular Medicine, Microbiology, Epidemiology and Pediatrics, Perinatology and Child Health, having authored 124 papers that have together received 3.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (38 papers), Pneumonia and Respiratory Infections (23 papers), Bacterial Infections and Vaccines (14 papers), Respiratory viral infections research (13 papers), Antibiotic Resistance in Bacteria (12 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Influenza Virus Research Studies (7 papers). The work is most often cited by research in Microbiology (874 citations), Molecular Medicine (353 citations), Pharmacology (886 citations), Epidemiology (1.6k citations) and Applied Microbiology and Biotechnology (66 citations). Marc Lebel has collaborated with scholars based in Canada, United States and France. Frequent co-authors include George H. McCracken, François Vallée, Michel G. Bergeron, Kurt Olsen, George A. Syrogiannopoulos, Sunita M. Stewart, Betsy D. Kennard, Bishara J. Freij, Dale F. Chrane and Marie Gauthier. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Pediatric Infectious Disease Journal, Clinical Pharmacology & Therapeutics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.